INSPRA Side Effects

5829603-4 | Blood Creatinine Increased, Dehydration, Gastroenteritis, Renal Failure Acute
on Jul 21, 2008 Male patient from GERMANY , weighting 216.1 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, dehydration, gastroenteritis (What is gastroenteritis?), renal failure acute. Inspra dosage: Daily Dose:50mg. During the same period patient was treated with XIPAMIDE (View Xipamide Review and Xipamide Label ), TOREM (View Torem Review and Torem Label ), BENALAPRIL (View Benalapril Review and Benalapril Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

5823517-1 | Dehydration, Dizziness, Gait Disturbance, Headache, Nervousness, Nightmare, Polyuria
Patient was taking Inspra (View Usage). Patient had the following side effects: dehydration, dizziness (What is dizziness?), gait disturbance, headache (What is headache?), nervousness, nightmare, polyuria on Jul 15, 2008 from GERMANY Additional patient health information: Female patient , 75 years of age, . Inspra dosage: Text:half Tablet A Day. During the same period patient was treated with METOHEXAL (View Metohexal Review and Metohexal Label ), DIOVANE (View Diovane Review and Diovane Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CRATAEGUTT (View Crataegutt Review and Crataegutt Label ).

5754392-1 | Blood Creatinine Increased
Adverse event was reported on May 21, 2008 by a Male patient taking Inspra (View Usage) (Dosage: ) was diagnosed with cardiac failure, implantable defibrillator insertion and. Location: GERMANY , weighting 194.0 lb, After Inspra was administered, patient had the following side effects: blood creatinine increased. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TOREM (View Torem Review and Torem Label ), IDEOS (View Ideos Review and Ideos Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ), DELIX (View Delix Review and Delix Label ).

5720377-4 | Blood Sodium Decreased, Pyrexia, Upper Respiratory Tract Infection
on Apr 16, 2008 Male patient from UNITED STATES , 79 years of age, weighting 150.3 lb, was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, pyrexia, upper respiratory tract infection. Inspra dosage: . During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.


5720331-2 | Atrial Fibrillation
on Apr 17, 2008 Male patient from NETHERLANDS , weighting 205.0 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Inspra dosage: .

5671394-4 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased on Mar 06, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 71 years of age, weighting 183.0 lb, was diagnosed with cardiac failure, atrial fibrillation (What is atrial fibrillation?), type 2 diabetes mellitus and. Inspra dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), NOVOLOG MIX 70/30 (View Novolog Mix 70/30 Review and Novolog Mix 70/30 Label ).

5662302-0 | Hypokalaemia
Adverse event was reported on Feb 29, 2008 by a Male patient taking Inspra (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: FRANCE , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: hypokalaemia. During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), NEXIUM (View Nexium Review and Nexium Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), PLAVIX (View Plavix Review and Plavix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ).

5643722-7 | Atrial Fibrillation
on Feb 19, 2008 Male patient from , weighting 205.0 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Inspra dosage: .

5537929-7 | Hyperhidrosis, Pruritus
on Nov 28, 2007 Male patient from UNITED KINGDOM , weighting 168.0 lb, was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: hyperhidrosis, pruritus. Inspra dosage: .

5491058-X | Hyperglycaemia
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia on Oct 09, 2007 from MEXICO Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with dyspnoea and. Inspra dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), JANUVIA (Daily Dose:100mg-freq:daily) (View Januvia Review and Januvia Label ), IMDUR (Daily Dose:60mg-freq:daily) (View Imdur Review and Imdur Label ), COZAAR (Daily Dose:50mg-freq:daily) (View Cozaar Review and Cozaar Label ), DIACEREIN (Daily Dose:50mg-freq:daily) (View Diacerein Review and Diacerein Label ).

5463544-X | Psoriasis
Adverse event was reported on Sep 04, 2007 by a Male patient taking Inspra (View Usage) (Dosage: ) was diagnosed with cardiac failure and. Location: UNITED KINGDOM , 69 years of age, weighting 220.5 lb, Patient had the following side effects: psoriasis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5408838-9 | Dizziness, Gait Disturbance, Headache, Renal Impairment
on Jul 27, 2007 Male patient from UNITED KINGDOM , 79 years of age, weighting 191.8 lb, was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: dizziness (What is dizziness?), gait disturbance, headache (What is headache?), renal impairment. Inspra dosage: Text:25mg. Patient was hospitalized and became disabled.

5405392-2 | Platelet Count Decreased
on Apr 20, 2007 Male patient from FRANCE , 55 years of age, was diagnosed with cardiomyopathy (What is cardiomyopathy?) and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Inspra dosage: . During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), KREDEX (Daily Dose:25mg-freq:daily) (View Kredex Review and Kredex Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ).

5384584-5 | Acute Hepatic Failure, Coagulopathy, Haemorrhage, Nausea, Renal Failure Acute, Thrombocytopenia
Patient was taking Inspra (View Usage). Patient had the following side effects: acute hepatic failure, coagulopathy, haemorrhage, nausea (What is nausea?), renal failure acute, thrombocytopenia on Jul 02, 2007 from GERMANY Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with myocardial infarction, cardiac failure and. Inspra dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), LASIX (View Lasix Review and Lasix Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GODAMED (View Godamed Review and Godamed Label ), ACTRAPHANE HM (View Actraphane Hm Review and Actraphane Hm Label ). Patient was hospitalized.

5382306-5 | Depression, Muscle Spasms, Myalgia, Nightmare, Vitamin D Deficiency
Adverse event was reported on Jun 29, 2007 by a Male patient taking Inspra (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , weighting 164.9 lb, After Inspra was administered, patient had the following side effects: depression (What is depression?), muscle spasms, myalgia, nightmare, vitamin d deficiency. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

5379322-6 | Depression, Gastrointestinal Disorder
on Jun 26, 2007 Female patient from GERMANY , weighting 138.9 lb, was diagnosed with cardiac failure, myocardial infarction and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), gastrointestinal disorder. Inspra dosage: Daily Dose:25mg. During the same period patient was treated with NEBILET (Text:total Daily Dose 1 Tablet) (View Nebilet Review and Nebilet Label ), CORDARONE (Daily Dose:200mg) (View Cordarone Review and Cordarone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5377730-0 | Aplastic Anaemia, Neutropenia
on Jun 21, 2007 Male patient from FRANCE , 82 years of age, was treated with Inspra (View Usage). Patient had the following side effects: aplastic anaemia, neutropenia. Inspra dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), IKOREL (View Ikorel Review and Ikorel Label ), VASTAREL (View Vastarel Review and Vastarel Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

5375562-0 | Acute Hepatic Failure, Coagulopathy, Haemorrhage, Renal Failure Acute, Thrombocytopenia
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: acute hepatic failure, coagulopathy, haemorrhage, renal failure acute, thrombocytopenia on Jun 19, 2007 from GERMANY Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with cardiac failure and. Inspra dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ACTRAPHANE HM (View Actraphane Hm Review and Actraphane Hm Label ).

5349856-9 | Gynaecomastia, Haematuria
Adverse event was reported on May 29, 2007 by a Male patient taking Inspra (View Usage) (Dosage: ) . Location: GERMANY , weighting 220.5 lb, Patient experienced the following unwanted or unexpected effects: gynaecomastia, haematuria. During the same period patient was treated with OSYROL (View Osyrol Review and Osyrol Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), ALNA (View Alna Review and Alna Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), FRAGMIN (View Fragmin Review and Fragmin Label ).

5322723-2 | Blood Glucose Increased, Hyperhidrosis, Visual Disturbance
on May 02, 2007 Male patient from GERMANY , 42 years of age, weighting 205.0 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient had the following side effects: blood glucose increased, hyperhidrosis, visual disturbance. Inspra dosage: Daily Dose:25mg-freq:daily. During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

5317279-4 | Depression, Muscle Spasms, Myalgia, Nightmare, Vitamin D Deficiency
on Apr 24, 2007 Male patient from UNITED STATES , weighting 164.9 lb, was diagnosed with hypertension and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: depression (What is depression?), muscle spasms, myalgia, nightmare, vitamin d deficiency. Inspra dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

5310660-9 | Malaise, Tinnitus, Vertigo
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, tinnitus (What is tinnitus?), vertigo on Apr 18, 2007 from FRANCE Additional patient health information: Male patient , 42 years of age, . Inspra dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

5288956-9 | Acute Coronary Syndrome, Priapism, Urethral Haemorrhage
Adverse event was reported on Mar 27, 2007 by a Male patient taking Inspra (View Usage) (Dosage: Daily Dose:50mg-freq:daily) was diagnosed with cardiac failure and. Location: GERMANY , weighting 165.3 lb, Patient had the following side effects: acute coronary syndrome, priapism, urethral haemorrhage. During the same period patient was treated with COVERSUM (View Coversum Review and Coversum Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CYNT (View Cynt Review and Cynt Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ENAHEXAL (View Enahexal Review and Enahexal Label ). Patient was hospitalized.

5269386-2 | Platelet Count Decreased
on Mar 07, 2007 Male patient from FRANCE , 55 years of age, was diagnosed with cardiomyopathy (What is cardiomyopathy?) and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: platelet count decreased. Inspra dosage: . During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), KREDEX (Daily Dose:25mg-freq:daily) (View Kredex Review and Kredex Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ).

5266585-0 | Blood Glucose Increased, Increased Insulin Requirement
on Mar 06, 2007 Male patient from GERMANY , 72 years of age, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, increased insulin requirement. Inspra dosage: . During the same period patient was treated with INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), LANTUS (View Lantus Review and Lantus Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), UNAT (View Unat Review and Unat Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ).

5254480-2 | Atrial Fibrillation, Diabetes Mellitus Inadequate Control
Patient was taking Inspra (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), diabetes mellitus inadequate control on Feb 20, 2007 from FRANCE Additional patient health information: Male patient , weighting 160.9 lb, was diagnosed with primary hyperaldosteronism, atrial fibrillation (What is atrial fibrillation?) and. Inspra dosage: . During the same period patient was treated with CORDARONE (Text:2 Dose Forms) (View Cordarone Review and Cordarone Label ), AMLODIPINE (Daily Dose:10mg) (View Amlodipine Review and Amlodipine Label ), OLMETEC (Daily Dose:40mg) (View Olmetec Review and Olmetec Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), GLICLAZIDE (Daily Dose:60mg) (View Gliclazide Review and Gliclazide Label ).

5207831-9 | Hyperbilirubinaemia, Jaundice, Reticulocytosis
Adverse event was reported on Jan 04, 2007 by a Male patient taking Inspra (View Usage) (Dosage: Daily Dose:25mg-freq:every Day) was diagnosed with ischaemic cardiomyopathy, cardiac failure and. Location: FRANCE , 67 years of age, weighting 185.2 lb, After Inspra was administered, patient had the following side effects: hyperbilirubinaemia, jaundice (What is jaundice?), reticulocytosis. During the same period patient was treated with FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ). Patient was hospitalized.

5202536-2 | Blood Potassium Increased
on Nov 14, 2005 Female patient from UNITED STATES , 58 years of age, weighting 120.0 lb, was diagnosed with hypertension and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased. Inspra dosage: 25 Mg (25 Mg, 1 In 24 Hr) Oral. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), LIPITOR (View Lipitor Review and Lipitor Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

5197662-0 | Arthritis
on Dec 14, 2006 Male patient from IRELAND , 71 years of age, weighting 160.1 lb, was diagnosed with blood pressure abnormal and was treated with Inspra (View Usage). Patient had the following side effects: arthritis (What is arthritis?). Inspra dosage: Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NEBIVOLOL (NEBIVOLOL) (View Nebivolol (nebivolol) Review and Nebivolol (nebivolol) Label ), FELODIPINE (View Felodipine Review and Felodipine Label ).

5195213-8 | Arthritis, Muscle Strain, Oedema Peripheral
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: arthritis (What is arthritis?), muscle strain, oedema peripheral on Oct 20, 2006 from IRELAND Additional patient health information: Male patient , 71 years of age, weighting 160.1 lb, was diagnosed with blood pressure abnormal and. Inspra dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), FELODIPINE (View Felodipine Review and Felodipine Label ).

5194386-0 | Anuria, Circulatory Collapse
Adverse event was reported on Dec 19, 2006 by a Male patient taking Inspra (View Usage) (Dosage: ) . Location: FRANCE , 70 years of age, Patient experienced the following unwanted or unexpected effects: anuria, circulatory collapse. During the same period patient was treated with CARDENSIEL (View Cardensiel Review and Cardensiel Label ).

5191180-1 | Cardiac Arrest, Constipation, Dialysis, Diarrhoea, Hepatic Failure, Renal Failure
on Dec 06, 2006 Male patient from GERMANY , 78 years of age, was diagnosed with congestive cardiomyopathy and was treated with Inspra (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), constipation (What is constipation?), dialysis (What is dialysis?), diarrhoea, hepatic failure, renal failure. Inspra dosage: 50 Mg, Oral. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), PANTOZOL (PANTOPRAZOLE SODIUM) (View Pantozol (pantoprazole Sodium) Review and Pantozol (pantoprazole Sodium) Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ).

5189880-2 | Cerebral Haemorrhage, Condition Aggravated, Dialysis, Fall, Nephropathy Toxic, Renal Failure Chronic, Somnolence, Traumatic Brain Injury
on Dec 07, 2006 Male patient from GERMANY , 80 years of age, weighting 187.4 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: cerebral haemorrhage, condition aggravated, dialysis (What is dialysis?), fall (What is fall?), nephropathy toxic, renal failure chronic, somnolence, traumatic brain injury (What is traumatic brain injury?). Inspra dosage: 25 Mg, Oral. During the same period patient was treated with ANGIOTENSIN II ANTAGONISTS (ANGIOTENSIN II ANTAGONISTS) (View Angiotensin Ii Antagonists (angiotensin Ii Antagonists) Review and Angiotensin Ii Antagonists (angiotensin Ii Antagonists) Label ), BETA BLOCKING AGENTS (BETA BLOCKING AGENTS) (View Beta Blocking Agents (beta Blocking Agents) Review and Beta Blocking Agents (beta Blocking Agents) Label ), DIURETICS (DIURETICS) (View Diuretics (diuretics) Review and Diuretics (diuretics) Label ), ATACAND (View Atacand Review and Atacand Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5186948-1 | Angioneurotic Oedema, Arrhythmia, Blood Glucose Increased, Hypersensitivity, Hypertension
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: angioneurotic oedema, arrhythmia (What is arrhythmia?), blood glucose increased, hypersensitivity, hypertension on Dec 01, 2006 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 140.0 lb, was diagnosed with hypertension, diabetes mellitus, arrhythmia (What is arrhythmia?) and. Inspra dosage: 100 Mg (50 Mg, Bid), Oral. During the same period patient was treated with GLYBURIDE (5 Mg (5 Mg, Qd), Oral) (View Glyburide Review and Glyburide Label ), LANOXIN (0.25 Mg (0.25 Mg, Qd), Oral) (View Lanoxin Review and Lanoxin Label ), METHYLDOPA (3000 Mg (1000 Mg, Tid), Oral) (View Methyldopa Review and Methyldopa Label ), ALDOMET (View Aldomet Review and Aldomet Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

5170633-6 | Blood Glucose Increased, Increased Insulin Requirement
Adverse event was reported on Nov 22, 2006 by a Male patient taking Inspra (View Usage) (Dosage: Oral) was diagnosed with cardiac failure and. Location: GERMANY , 72 years of age, Patient had the following side effects: blood glucose increased, increased insulin requirement. During the same period patient was treated with INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), LANTUS (View Lantus Review and Lantus Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), UNAT (TORASEMIDE) (View Unat (torasemide) Review and Unat (torasemide) Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ).

5170364-2 | Cerebral Haemorrhage, Dialysis, Fall, Renal Failure, Somnolence, Traumatic Brain Injury
on Nov 27, 2006 Male patient from GERMANY , 80 years of age, weighting 187.4 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: cerebral haemorrhage, dialysis (What is dialysis?), fall (What is fall?), renal failure, somnolence, traumatic brain injury (What is traumatic brain injury?). Inspra dosage: 25 Mg, Oral. During the same period patient was treated with ANGIOTENSIN II ANTAGONISTS (ANGIOTENSIN II ANTAGONISTS) (View Angiotensin Ii Antagonists (angiotensin Ii Antagonists) Review and Angiotensin Ii Antagonists (angiotensin Ii Antagonists) Label ), BETA BLOCKING AGENTS (BETA BLOCKER AGENTS) (View Beta Blocking Agents (beta Blocker Agents) Review and Beta Blocking Agents (beta Blocker Agents) Label ), DIURETICS (DIURETICS) (View Diuretics (diuretics) Review and Diuretics (diuretics) Label ).

5165538-0 | Blood Glucose Increased
on Nov 10, 2006 Male patient from GERMANY , 71 years of age, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased. Inspra dosage: 25 Mg (25 Mg, Daily), Oral. During the same period patient was treated with INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), BETA BLOCKING AGENTS (BETA BLOCKING AGENTS) (View Beta Blocking Agents (beta Blocking Agents) Review and Beta Blocking Agents (beta Blocking Agents) Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), DIGITALIS CAP (View Digitalis Cap Review and Digitalis Cap Label ).

5165528-8 | Atrial Fibrillation
Patient was taking Inspra (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Nov 10, 2006 from GERMANY Additional patient health information: Male patient , 55 years of age, was diagnosed with cardiac failure and. Inspra dosage: Oral. During the same period patient was treated with LORZAAR PLUS (HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM) (View Lorzaar Plus (hydrochlorothiazide, Losartan Potassium) Review and Lorzaar Plus (hydrochlorothiazide, Losartan Potassium) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), EZETIMIBE/SIMVASTATIN (EZETIMIBE, SIMVASTATIN) (View Ezetimibe/simvastatin (ezetimibe, Simvastatin) Review and Ezetimibe/simvastatin (ezetimibe, Simvastatin) Label ). Patient was hospitalized.

5117182-9 | Angioneurotic Oedema, Arrhythmia, Blood Glucose Increased, Hypersensitivity, Hypertension, Treatment Noncompliance
Adverse event was reported on Sep 14, 2006 by a Female patient taking Inspra (View Usage) (Dosage: 100 Mg (50 Mg, Bid); Oral) was diagnosed with hypertension, diabetes mellitus, arrhythmia (What is arrhythmia?) and. Location: UNITED STATES , 72 years of age, weighting 140.0 lb, After Inspra was administered, patient had the following side effects: angioneurotic oedema, arrhythmia (What is arrhythmia?), blood glucose increased, hypersensitivity, hypertension, treatment noncompliance. During the same period patient was treated with GLIBENCLAMIDE TABLET (GLIBENCLAMIDE) (5 Mg (5 Mg, Qd); Oral) (View Glibenclamide Tablet (glibenclamide) Review and Glibenclamide Tablet (glibenclamide) Label ), LANOXIN (0.25 Mg (0.25 Mg, Qd) Oral) (View Lanoxin Review and Lanoxin Label ), METHYLDOPA (3000 Mg (1000 Mg, Tid); Oral) (View Methyldopa Review and Methyldopa Label ). Patient was hospitalized.

5117104-0 | Asthenia, Cellulitis, Cholecystitis Acute, Coordination Abnormal, Dehydration, Dyskinesia, Dyspnoea, Exercise Test Abnormal, Hyperhidrosis
on Aug 14, 2006 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with cardiac failure chronic and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cellulitis (What is cellulitis?), cholecystitis acute, coordination abnormal, dehydration, dyskinesia, dyspnoea, exercise test abnormal, hyperhidrosis. Inspra dosage: (25 Mg), Oral. Patient was hospitalized.

5117096-4 | Blood Glucose Increased, Hyperhidrosis, Visual Disturbance
on Sep 12, 2006 Male patient from GERMANY , 42 years of age, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient had the following side effects: blood glucose increased, hyperhidrosis, visual disturbance. Inspra dosage: 25 Mg (daily), Oral; 3 Weeks Ago. During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5115116-4 | Dyskinesia, Malaise, Swollen Tongue
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: dyskinesia, malaise, swollen tongue on Sep 11, 2006 from UNITED STATES Additional patient health information: Female patient , 88 years of age, was diagnosed with blood pressure (What is blood pressure?) and. Inspra dosage: 25 Mg (25 Mg, Frequency: Qd Interval: Every Day). During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), PLAVIX (View Plavix Review and Plavix Label ), DEMADEX (View Demadex Review and Demadex Label ), ACETYLSALICYCLIC AICD (ACETYLSALICYLIC ACID) (View Acetylsalicyclic Aicd (acetylsalicylic Acid) Review and Acetylsalicyclic Aicd (acetylsalicylic Acid) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ).

5099794-4 | Cardiac Failure, Condition Aggravated, Dialysis, Dizziness, Leukocytosis, Lymphopenia, Neutrophil Count Increased, Pneumonia, Renal Failure Acute
Adverse event was reported on Aug 23, 2006 by a Male patient taking Inspra (View Usage) (Dosage: ) was diagnosed with cardiac failure and. Location: GERMANY , 73 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure, condition aggravated, dialysis (What is dialysis?), dizziness (What is dizziness?), leukocytosis, lymphopenia, neutrophil count increased, pneumonia (What is pneumonia?), renal failure acute. During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), TOREM (TORASEMIDE) (View Torem (torasemide) Review and Torem (torasemide) Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ).

5074146-1 | Cardiac Arrest, Cardiac Disorder, Fall, Hypertension, Hypoaesthesia, Hypoxic Encephalopathy, Paraesthesia, Ventricular Fibrillation
on Jul 24, 2006 Male patient from UNITED KINGDOM , 66 years of age, weighting 134.5 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardiac disorder, fall (What is fall?), hypertension, hypoaesthesia, hypoxic encephalopathy, paraesthesia, ventricular fibrillation. Inspra dosage: 12.5 Mg (12.5 Mg, Daily: Every Day), Oral. During the same period patient was treated with BUMETANIDE (View Bumetanide Review and Bumetanide Label ), BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE) (View Bendroflumethiazide (bendroflumethiazide) Review and Bendroflumethiazide (bendroflumethiazide) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), NICORANDIL (NICORANDIL) (View Nicorandil (nicorandil) Review and Nicorandil (nicorandil) Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), SERETIDE (FLUTCIASONE PROPIONATE, SALMETEROL XINAFOATE) (View Seretide (flutciasone Propionate, Salmeterol Xinafoate) Review and Seretide (flutciasone Propionate, Salmeterol Xinafoate) Label ), SALBUTAMOL (SALBUTAMOL) (View Salbutamol (salbutamol) Review and Salbutamol (salbutamol) Label ).

5044312-X | Aggression, Fatigue, Nervousness, Sensory Disturbance, Somnolence
on Jun 19, 2006 Male patient from GERMANY , 52 years of age, weighting 200.6 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: aggression, fatigue, nervousness, sensory disturbance, somnolence. Inspra dosage: 50 Mg Daily, Oral. During the same period patient was treated with TORSEMIDE (View Torsemide Review and Torsemide Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), ATACAND PLUS (CANDESARTAN CILEXETIL, HYDROCHLOROTHIA (View Atacand Plus (candesartan Cilexetil, Hydrochlorothia Review and Atacand Plus (candesartan Cilexetil, Hydrochlorothia Label ), BELOC ZOK MITE (METOPROLOL SUCCINATE) (View Beloc-zok Mite (metoprolol Succinate) Review and Beloc-zok Mite (metoprolol Succinate) Label ).

5030673-4 | Acute Myocardial Infarction, Anuria, Cardiogenic Shock, Coronary Artery Stenosis, Facial Palsy, Hemiparesis, Hemiplegia, Hypotension, Loss Of Consciousness
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, anuria, cardiogenic shock, coronary artery stenosis, facial palsy, hemiparesis, hemiplegia, hypotension, loss of consciousness on Jun 04, 2006 from ISRAEL Additional patient health information: Male patient , 58 years of age, was diagnosed with cardiac failure congestive and. Inspra dosage: (25 Mg). During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SIMOVIL (SIMVASTATIN) (View Simovil (simvastatin) Review and Simovil (simvastatin) Label ), DIMITONE (CARVEDILOL) (View Dimitone (carvedilol) Review and Dimitone (carvedilol) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MICROPIRIN (ACETYLSALICYLIC ACID) (View Micropirin (acetylsalicylic Acid) Review and Micropirin (acetylsalicylic Acid) Label ).

5026267-7 | Blood Potassium Increased, Hyperkalaemia, Lower Respiratory Tract Infection, Renal Failure Acute
Adverse event was reported on May 31, 2006 by a Female patient taking Inspra (View Usage) (Dosage: 25 Mg (25 Mg, Daily), Oral) was diagnosed with cardiac failure and. Location: UNITED KINGDOM , 82 years of age, weighting 162.3 lb, Patient had the following side effects: blood potassium increased, hyperkalaemia, lower respiratory tract infection, renal failure acute. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), PERINDOPRIL (PERINDOPRIL) (View Perindopril (perindopril) Review and Perindopril (perindopril) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

5024448-X | Depressed Mood, Depression, Tearfulness
on May 26, 2006 Female patient from UNITED KINGDOM , 44 years of age, weighting 131.6 lb, was diagnosed with hypertension, primary hyperaldosteronism and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: depressed mood, depression (What is depression?), tearfulness. Inspra dosage: 25 Mg, Oral. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ).

5019124-3 | Difficulty In Walking, Myalgia, Pain In Extremity
on May 22, 2006 Female patient from UNITED STATES , 67 years of age, weighting 100.0 lb, was diagnosed with hypertension and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: difficulty in walking, myalgia, pain in extremity. Inspra dosage: (50 Mg), Oral. During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), VASOTEC (View Vasotec Review and Vasotec Label ), ATACAND (View Atacand Review and Atacand Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5019122-X | Cough, Depressed Level Of Consciousness, Fatigue, Loss Of Consciousness, Throat Irritation
Patient was taking Inspra (View Usage). Patient had the following side effects: cough, depressed level of consciousness, fatigue, loss of consciousness, throat irritation on May 22, 2006 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 211.0 lb, was diagnosed with cardiac failure congestive and. Inspra dosage: 25 Mg (25 Mg, Daily Interval: Every Day), Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).